We observed that ERBB2/HER2-enriched breast cancer was associated with BMI at 35 years or younger but not at later ages; the Nurses’ Health Study, included in this analysis, previously reported a strong association with BMI at 18 years of age,7 but we are not aware of studies investigating the association with later premenopausal ages. The gene discussed is ERBB2; the disease is breast cancer.